Drug Profile
GRE 213
Alternative Names: GRE-213Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Grespo
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Neurodegenerative disorders
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in Neurodegenerative-disorders in Sweden
- 20 Jul 2016 Early research in Neurodegenerative disorders in Sweden (unspecified route)